Indeed, CDK18's role in facilitating efficient cellular responses to replication stress make it an attractive therapeutic target in many cancers, including in breast cancer where strong associations between oestrogen receptor signalling, cell proliferation and replication stress are emerging [2, 38, 39]. The gene discussed is CDK18; the disease is breast carcinoma.